Eisai opens new Global Capability Centre
The IT hub in Visakhapatnam, India, standardizes global IT operations and drives digital transformation. An opening ceremony celebrated its launch.
See the latest news and media coverage for Eisai. We track all announcements, press releases, and industry mentions in real time, all in one place.
Human health care company
eisai.comLast updated
In short: Eisai announced a $7 billion three-year investment plan and aims for $7 billion in revenue by 2028, driven by the expansion of its Alzheimer's drug.
The IT hub in Visakhapatnam, India, standardizes global IT operations and drives digital transformation. An opening ceremony celebrated its launch.
Eisai earns 'Thought Leaders of Human Capital 2025' and 'Human Capital Management Excellence 2025 Gold Award' for excellent management and disclosure.
The application for subcutaneous starting dose in early Alzheimer’s is under priority review with action date May 24, 2026.
It marks Eisai's tenth inclusion and highest rank among global pharmaceutical companies. Evaluation based on UN SDGs, sustainable revenue, and investment.
(1:40 p.m., Prime, code 4523) Eisai is falling. It hit 3873 yen in the afternoon, down 96 yen (2.41%) from the previous day. SBI Securities lowered its target price for Eisai from the previous 4740 yen to 3930 yen in a report dated the 18th, and selling appears to be driven by this news. The investment rating remains at "neutral," the middle of three levels. Regarding the first administration of the subcutaneous injection formulation of the Alzheimer's disease treatment drug "Leqembi" being developed by the company, the U.S. Food and Drug Administration (FDA...
As its main anticancer drug faces patent expiration, 'We will continue strategic efforts to evolve as a 'sharp drug discovery company',' emphasizes Keisuke Naito, Executive Officer, COO and Chief Growth Officer of Eisai. The company announced a three-year plan...
We will send newsletters and campaign information for the Nikkei electronic edition to the email address you registered (you can unsubscribe after registration). We will use your email address only for the purpose of sending these emails. You will not be automatically registered for other services such as Nikkei ID. Thank you for registering. We have sent an email to the email address you provided. Click the link in the email to read the full article...
As the United Kingdom juggles industry concerns about the region's waning appeal and competitiveness, Eisai is getting a lift from a production-tinged fund that the...
Track Eisai and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Eisai and other trending companies.